Brigham and Women's Hospital
Pathology
Dr. Michael Miller carried out his undergraduate studies in the Grinnell College inquiry-based biological chemistry curriculum, then worked on genetic imprinting with Dr. Karl Pfeifer at the U.S. National Institutes of Health. Dr. Miller received his M.D., Ph.D. training at the Geisel School of Medicine at Dartmouth, where he completed his thesis research in biochemistry with Dr. Surachai Supattapone , studying the mechanism of formation and propagation of infectious mammalian prions. Dr. Miller completed his residency in Anatomic Pathology at Brigham and Women’s Hospital, and Neuropathology fellowship at Brigham and Women’s, Boston Children’s, and Beth Israel Deaconess Hospitals. Dr. Miller is now Instructor at Harvard Medical School, Associate Pathologist at Brigham and Women’s Hospital, and research fellow in the group of Dr. Christopher Walsh at Boston Children’s Hospital, where he studies the role of brain somatic mutations in neurodegenerative diseases.

Moderator of 1 Session

Session Type
SYMPOSIUM
Date
Wed, 16.03.2022
Session Time
08:30 AM - 10:30 AM
Room
ONSITE: 131-132

Presenter of 1 Presentation

EXCESSIVE SOMATIC MUTATIONS WITH DISTINCTIVE PATTERNS IN ALZHEIMER’S DISEASE NEURONS REVEALED BY NOVEL SINGLE-CELL WHOLE GENOME SEQUENCING METHOD

Session Type
SYMPOSIUM
Date
Wed, 16.03.2022
Session Time
08:30 AM - 10:30 AM
Room
ONSITE: 131-132
Lecture Time
09:00 AM - 09:15 AM

Abstract

Aims

Alzheimer’s disease (AD) is characterized pathologically by deposition of misfolded amyloid-β and tau proteins. However, protein-directed therapeutic strategies have shown limited clinical benefit, pointing to the need to examine pathogenesis from a broader lens.

Neurons each harbor somatic single nucleotide variants (sSNV) in their genomes, which increase with age, at a rate of ~15-20 sSNV per year. In AD, DNA damage is increased, with potentially significant effects on the genome of each cell.

Methods

We performed single-cell whole genome sequencing on neurons from AD and age-matched controls, using two independent genome amplification methods, and analyzed the burden of somatic mutations and associated nucleotide change signatures for mutational patterns.

Results

We found significantly increased sSNV in AD, with hundreds of additional somatic mutations per neuron, and a distinct mutation pattern. AD neurons show an increase in Signature C, which contains distinct nucleotide changes including C>A variants. We find elevated 8-Oxoguanine DNA lesions, evidence that these mutations may result from oxidative DNA damage. Mutations also show influences of transcription in sSNV generation. Somatic mutations are predicted to produce deleterious effects on the neuron, including gene inactivation and neoantigen-stimulated immune attack.

Conclusions

AD neurons show increased somatic mutations, with mutagenic causes that illuminate upstream components of disease pathogenesis, including DNA oxidation and transcription-coupled DNA repair. Somatic mutations further predispose neurons for dysfunction and death. The identification of somatic mutation accumulation as a novel element of neurodegeneration will enable further dissection of the cascade of events in disease pathogenesis.

Hide